Aclarion (ACON) Research & Development (2021 - 2026)
Aclarion (ACON) posted Research & Development of $315417.0 for Q1 2026, down 49.28% on a QoQ basis from $621839.0 in Q4 2025, and up 59.15% year-over-year from $198190.0 in Q1 2025.
Aclarion (ACON) Research & Development (2021 - 2026) Analysis & Trends
Aclarion's Research & Development history runs 6 years deep, the most recent figure standing at $315417.0 for Q1 2026.
- Quarterly Research & Development rose 59.15% year-over-year to $315417.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 86.7% YoY) and the FY2025 annual result came in at $1.9 million, up 113.85% from the prior year.
- Research & Development was $315417.0 for Q1 2026 at Aclarion, down from $621839.0 in the prior quarter.
- Across five years, Research & Development topped out at $621839.0 in Q4 2025 and bottomed at -$350992.0 in Q4 2022.
- A 5-year average of $222531.2 and a median of $202102.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 443.75% — and 2023, when it declined 29.22%.
- Aclarion's Research & Development stood at -$350992.0 in 2022, then surged by 151.01% to $179035.0 in 2023, then surged by 40.66% to $251826.0 in 2024, then jumped by 146.93% to $621839.0 in 2025, then plunged by 49.28% to $315417.0 in 2026.
- Business Quant data shows ACON's Research & Development at $315417.0 in Q1 2026, $621839.0 in Q4 2025, and $302037.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 56.85 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 30.34 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 45.83 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 39.11 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 8.13 Mn |
| 10 | Aclarion | 151.90 | 151.90 | 3,750.00 | 315,417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315,417.00 |
| Dec 31, 2025 | 621,839.00 |
| Sep 30, 2025 | 302,037.00 |
| Jun 30, 2025 | 343,765.00 |
| Mar 31, 2025 | 198,190.00 |
| Dec 31, 2024 | 251,826.00 |
| Sep 30, 2024 | 195,797.00 |
| Jun 30, 2024 | 202,102.00 |
| Mar 31, 2024 | 181,056.00 |
| Dec 31, 2023 | 179,035.00 |
| Sep 30, 2023 | 198,252.00 |
| Jun 30, 2023 | 250,006.00 |
| Mar 31, 2023 | 177,284.00 |
| Dec 31, 2022 | -350,992.00 |
| Sep 30, 2022 | 159,388.00 |
| Jun 30, 2022 | 353,226.00 |
| Mar 31, 2022 | 204,803.00 |
| Dec 31, 2021 | -274,935.00 |
| Sep 30, 2021 | 78,377.00 |
| Jun 30, 2021 | 64,961.00 |